Clinical Trial Update: Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update indicating completion of a study evaluating long-acting tacrolimus for resistant lupus nephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Long-Acting Tacrolimus (Tacrolimus)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Lupus Nephritis | Phase 4 | Status: COMPLETED